Publications by authors named "Martin H Ruttledge"

Claim this Profile
T
Two-year, real-world erenumab persistence and quality of life data in 82 pooled patients with abrupt onset, unremitting, treatment refractory headache and a migraine phenotype: New daily persistent headache or persistent post-traumatic headache in the majority of cases.
Alina Buture, Esther M Tomkins, Arif Shukralla, Emma Troy, Katie Conaty, Martin H Ruttledge

Cephalalgia· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Medium-term real-world data for erenumab in 177 treatment resistant or difficult to treat chronic migraine patients: persistence and patient reported outcome measures after 17-30 months.
Emma Troy, Arif A Shrukalla, Alina Buture, Katie Conaty, Esther Macken, Martin H Ruttledge

J Headache Pain· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Initial use of a novel noninvasive vagus nerve stimulator for cluster headache treatment.
Alexander D Nesbitt, Juana C A Marin, Esther Tompkins, Martin H Ruttledge, Peter J Goadsby

Neurology· March 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Role of the neurofibromatosis type 2 gene in the development of tumors of the nervous system.
Martin H Ruttledge, Guy A Rouleau

Neurosurg Focus· November 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis